搜索替代詞:
harm » farm (擴展搜索)
revolves. » resolves. (擴展搜索), resolved. (擴展搜索), evolved. (擴展搜索)
resolve. » resolved. (擴展搜索)
Showing 61 - 80 results of 231 for search 'harm is ((((remove. OR remove.) OR revolves.) OR (involves. OR involved.)) OR resolve.)', 查詢時間: 0.07s Refine Results
  1. 61
    Participating parents’ responses to questions on Paracetamol-related practices.

    Participating parents’ responses to questions on Paracetamol-related practices. 由 Muhammad Saad Nadeem Butt (22486473)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  2. 62
    Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings.

    Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  3. 63
    Results of comparing visits within allergy groups using linear mixed models and post hoc analysis.

    Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  4. 64
    Results of comparing allergy groups within visits using linear mixed models and post hoc analysis.

    Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  5. 65
    Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference.

    Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  6. 66
    Results of comparing treatment groups within visits using linear mixed models and post hoc analysis.

    Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  7. 67
    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis.

    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  8. 68
    Results of comparing visits within treatment groups using linear mixed models and post hoc analysis.

    Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  9. 69
    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis.

    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  10. 70
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  11. 71
    Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  12. 72
    Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  13. 73
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  14. 74
    Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  15. 75
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  16. 76
    Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  17. 77
    Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study.

    Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. 由 Diana M. Hendrickx (1507435)

    出版 2025
    加到收藏夾
    Saved in:
  18. 78
    Results of the molecular docking.

    Results of the molecular docking. 由 Naisarg Patel (21772572)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  19. 79
    Interaction between the CFTR protein with drug molecules upon Molecular Docking.

    Interaction between the CFTR protein with drug molecules upon Molecular Docking. 由 Naisarg Patel (21772572)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  20. 80
    ADMET Scan Results.

    ADMET Scan Results. 由 Naisarg Patel (21772572)

    出版 2025
    主題:
    加到收藏夾
    Saved in:

檢索工具: